Treatment, Outcome and Prognostic Factors in Renal Cell Carcinoma - A Single Center Study (2000-2010).

J Cancer · 2016 · PMC4910584 · PMID 27313782

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Male patients showed a trend towards improved survival when compared to female patients (median OS 24.5 vs. 17.6 months, n.s.) Patients with a sarcomatoid component showed poorer outcome than patients without (median OS 11.1 vs. 24.5 months, n.s.).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.